PODD

As of 2026-09-11, PODD scores 42out of 100 on QNTM’s five-factor quantitative model, a low conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. PODD trades at $134.68, within its fair-value band.

PODD scores 42 out of 100 on QNTM's five-factor model — a low-conviction reading — at 42 the factor profile is among the weaker names in the universe. Its strongest factor is value at 66 (strong), where it screens cheap on the model's valuation inputs, followed by quality at 53. The weakest is momentum at 16, where price trend is the soft spot. Among Healthcare stocks it sits in the lower 33% of Healthcare names by composite.

On valuation, PODD is priced in the upper part of its recent range. The profile is lopsided — a few factors carry it while others drag, so the composite masks real disagreement underneath. The blended composite before the macro overlay was 42. Same-sector names the model rates nearby include HALO, THC, HNGE.

This is a descriptive factor read on PODD, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where PODD sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for PODD runs $91.78–$159.53. Current price $134.68 sits within its fair-value band. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-11.